4//SEC Filing
DEC TIMOTHY C 4
Accession 0001194020-25-000004
CIK 0001356576other
Filed
Aug 25, 8:00 PM ET
Accepted
Aug 26, 4:18 PM ET
Size
5.4 KB
Accession
0001194020-25-000004
Insider Transaction Report
Form 4
DEC TIMOTHY C
Senior Vice-President & CFO
Transactions
- Sale
Common Stock
2025-08-22$44.49/sh−11,780$524,092→ 1,246 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.40 to $44.66, inclusive. The Reporting Person undertakes to provide to Supernus Pharmaceuticals, Inc. ("Supernus"), any security holder of Supernus, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F2]Includes an aggregate of 345 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
Documents
Issuer
SUPERNUS PHARMACEUTICALS, INC.
CIK 0001356576
Entity typeother
Related Parties
1- filerCIK 0001194020
Filing Metadata
- Form type
- 4
- Filed
- Aug 25, 8:00 PM ET
- Accepted
- Aug 26, 4:18 PM ET
- Size
- 5.4 KB